Addressing racism in health services research
At the 2020 Academy Health Research Meeting, presenters dug deep into the subject on everyone's minds: How do we tackle structural racism within health services research? More
VIDEO: How much is too much for hospital CEO compensation?
In this latest edition of “Lown Hospitals Q&A,” Shannon Brownlee and Vikas Saini discuss trends in hospital executive pay and explain why the Lown Institute included pay equity as a metric on the Lown Institute Hospitals Index More
Conflicts running rampant in the Covid era
As our country faces difficult decisions about how to mitigate the pandemic, pharmaceutical companies are wielding their influence through contributions to policymakers, health care administrators, and journalists. More
How doctors and patients view statins for primary prevention?
A new qualitative study offers insights into why so many people at low risk of heart disease are taking statins. More
How hospital segregation contributes to racial health disparities
In a Washington Post op-ed, Paul Glastris and Phil Longman explain how our health care system makes it hard for hospitals to treat everyone regardless of race or need. More
VIDEO: Racism and hospital access
Everyone has been talking about structural racism in criminal justice, but what about health care? In this latest edition of "Lown Hospitals Q&A," Shannon Brownlee and Vikas Saini discuss what the Lown Hospitals Index inclusivity metric shows about race and hospital access. More
Nearly half of older adults get overscreened for cancer
A recent study in JAMA finds that nearly half of older adults are still screened for certain cancers above the recommended age. More
Who’s afraid of superbugs?
While everyone is focused on the current pandemic, how can we take actions now to reduce the threat of antibiotic resistance? More
Is the price of remdesivir too high or too low?
Experts weigh in on the recently revealed price of Covid-19 drug remdesivir. More
Will it take 50-100 years to get the right answer about tPA for stroke?
Do the potential benefits of thrombolytic drugs for acute stroke outweigh the potential harms? In a guest blog, Drs W. Ken Milne and Daniel Fatovich examine this issue in light of new evidence. More
“We set the bar high”: LIHI creators and hospital leaders on what makes a great hospital
What are the top hospitals in the country doing to excel in all three categories on the Lown Hospitals Index? At a recent event hosted by the Lown Institute, Washington Monthly, and Open Markets Institute, the creators of the Lown Index and leaders of some of the winning hospitals discussed how hospitals can go from good to great. More
Tackling our “drive to prescribe”
Members of the Lown Institute Working Group on Medication Overload gave a webinar presentation last week, which is available to watch now! More
Covid-19 puts more pressure on state budgets
State budgets have been squeezed over the past decade due in large part to the rising cost of health care, and Covid-19 is only making it worse. What can we do about this problem? More
PRESS RELEASE: Can 2020 Push Hospitals From Good To Great?
The new Lown Institute Hospitals Index assesses civic leadership, value, and outcomes at US Hospitals. More
The harms and benefits of blood thinners for older adults
In the latest edition of the American Family Physician's Right Care Series, doctors and patients discuss the benefits and harms of taking anticoagulants for atrial fibrillation in older adults. More
Bias in clinical algorithms make health disparities worse
A recent study from NEJM shows how inequality is “baked into the system” through clinical algorithms. More
Remdesivir report sparks more debate on drug price value
How much should remdesivir cost? This question puts two drug-value organizations at odds. More
Video: Science’s Viral Misinformation
Watch the video of Shannon Brownlee and Jeanne Lenzer discussing pandemic misinformation in a Future Tense conversation. More
Paying attention to the mental health effects of lockdown
Even though we have saved lives by locking down, we still have to address the effects of this decision on our country's mental health. More
Pharma sales reps still visiting doctors in the pandemic
Visits from pharmaceutical sales reps haven't stopped during the pandemic--they've just moved online... More